The petition was submitted by the Global Organization for EPA and DHA Omega 3s (GOED) and is based on the meta-analysis of 70 randomized controlled trials published earlier this year (and commissioned by GOED), which concluded that consuming omega-3 supplements or omega-3-rich food may be as effective as reducing sodium or alcohol, or increasing exercise for reducing blood pressure. Harry Rice, PhD, VP of regulatory & scientific affairs, for GOED, told NutraIngredients-USA that he is confident a qualified health claim will be allowed. He added that he is also hopeful that the FDA scientific review may elevate this to a full health claim.
In its letter in support of the GOED position, CRN noted that blood pressure reductions from supplementation with EPA and DHA compared favorably with other often-recommended lifestyle modifications including lowered sodium intake, more exercise and lowered alcohol intake. The average reduction for omega 3s was slightly less than what was observed with greater physical activity but exceeded the results of the other interventions.
The full text of CRN’s supporting letter can be seen here. The full text of GOED’s petition can be seen here.